AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$7.54 USD
-0.16 (-2.08%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.55 +0.01 (0.13%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth D Momentum B VGM
AngioDynamics (ANGO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.33 | $14.00 | $13.00 | 73.12% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for AngioDynamics comes to $13.33. The forecasts range from a low of $13.00 to a high of $14.00. The average price target represents an increase of 73.12% from the last closing price of $7.70.
Analyst Price Targets (3 )
Broker Rating
AngioDynamics currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/20/2024 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
7/17/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
7/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $13.33 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | -0.15 |
ANGO FAQs
AngioDynamics, Inc. (ANGO) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for AngioDynamics, Inc. (ANGO) is $13.33. The current on short-term price targets is based on 3 reports.
The forecasts for AngioDynamics, Inc. (ANGO) range from a low of $13 to a high of $14. The average price target represents a increase of $76.79 from the last closing price of $7.54.
The current UPSIDE for AngioDynamics, Inc. (ANGO) is 76.79%
Based on short-term price targets offered by three analysts, the average price target for AngioDynamics comes to $13.33. The forecasts range from a low of $13.00 to a high of $14.00. The average price target represents an increase of 73.12% from the last closing price of $7.70.